Zimmer Biomet has announced plans to phase out its CPT Hip System by December due to a higher risk of postoperative fractures compared to similar devices. The FDA issued a warning based on research showing a 1.4% risk of thigh bone fractures with the CPT Hip System, higher than the 0.6%-1% rate for comparable implants. The company previously issued a recall in July to update instructions for use.